Abstract
The Symetis ACURATE platform is designed for all transcatheter aortic valve implantation (TAVI) access routes: transfemoral, transapical, and transaortic. These bioprostheses are based on a unique, self-seating, and self-sealing design that allows for optimal positioning of the valve.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kempfert J, Möllmann H, Walther T. Symetis ACURATE TA valve. EuroIntervention. 2012;8:Q102–Q10.
Barbanti M, Webb JG, Gilard M, Capodanno D, Tamburino C. Transcatheter aortic valve implantation in 2017: state of the art. EuroIntervention. 2017;13:AA11–21.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Sgroi, C., Tamburino, C.I., Pilato, G. (2018). Transcatheter Aortic Valve Implantation: Boston ACURATE and ACURATE-neo TF. In: Tamburino, C., Barbanti, M., Capodanno, D. (eds) Percutaneous Treatment of Left Side Cardiac Valves. Springer, Cham. https://doi.org/10.1007/978-3-319-59620-4_23
Download citation
DOI: https://doi.org/10.1007/978-3-319-59620-4_23
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59619-8
Online ISBN: 978-3-319-59620-4
eBook Packages: MedicineMedicine (R0)